CLINICAL_TRIALS
trial_result
· 2011-07-12
Clinical Trial Update: N-methylglycine (Sarcosine) Treatment for Depression [Phase 2]
Summary
This clinical trial update reports the completion of a Phase 2 study evaluating sarcosine (N-methylglycine) for major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China Medical University Hospital | Conditions: Major Depressive Disorder, Depression | Phase 2 | Status: COMPLETED